Table 2.
Immune cell subpopulations in the control and PD group.
| Normal controls | PD patients | P-value | |
|---|---|---|---|
| WBC | 7368.4 ± 1584.4 | 7451.7 ± 2880.1 | 0.92 |
| Monocytes | 6.4 ± 1.07 | 6.29 ± 2.02 | 0.86 |
| CD14++CD16- | 88.8 (85.7, 92.5) | 87.9 (79.2, 0 90) | 0.32 |
| CD14+CD16++ | 4.11 (2.08, 4.88) | 4 (2.5, 6.22) | 0.87 |
| CD14++CD16+ | 4.75 ± 2.75 | 9.28 ± 6.36 | 0.002 |
| Lymphocytes (%) | 31.3 ± 5.54 | 22.3 ± 6.28 | <0.001 |
| T-lymphocytes (%) | 76.09 ± 7.11 | 76.8 ± 10.1 | 0.82 |
| B-lymphocytes (%) | 9.72 ± 3.63 | 6.39 ± 3.75 | 0.01 |
| NK cells (%) | 13.2 (8.62, 18.1) | 15.4 (9.67, 20.5) | 0.54 |
| Tregs (%) | 1.85 (1.48, 2.45) | 1.79 (1.34, 2.62) | 0.71 |
| CD4+ T cells (%) | 46.8 ± 7.65 | 50.1 ± 12.5 | 0.39 |
| CD8+ T cells (%) | 28.9 ± 9.24 | 25.6 ± 11.2 | 0.35 |
| CD4CD8 ratio | 1.74 (1.19, 2.24) | 1.91 (1.40, 3.18) | 0.36 |
Values are expressed in mean (±SD) or median (IQR 25–75th percentiles). CD, cluster of differentiation; NK, natural killer; Tregs, T regulatory cells.